167 related articles for article (PubMed ID: 38561883)
1. Challenges in Diagnosis and Treatment of Male Hypogonadism.
Purnamasari D
Acta Med Indones; 2024 Jan; 56(1):1-2. PubMed ID: 38561883
[TBL] [Abstract][Full Text] [Related]
2. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
Bhasin S; Brito JP; Cunningham GR; Hayes FJ; Hodis HN; Matsumoto AM; Snyder PJ; Swerdloff RS; Wu FC; Yialamas MA
J Clin Endocrinol Metab; 2018 May; 103(5):1715-1744. PubMed ID: 29562364
[TBL] [Abstract][Full Text] [Related]
3. Male hypogonadism : an update on diagnosis and treatment.
Darby E; Anawalt BD
Treat Endocrinol; 2005; 4(5):293-309. PubMed ID: 16185098
[TBL] [Abstract][Full Text] [Related]
4. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
5. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update.
Petak SM; Nankin HR; Spark RF; Swerdloff RS; Rodriguez-Rigau LJ;
Endocr Pract; 2002; 8(6):440-56. PubMed ID: 15260010
[TBL] [Abstract][Full Text] [Related]
6. Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy.
Yeap BB; Grossmann M; McLachlan RI; Handelsman DJ; Wittert GA; Conway AJ; Stuckey BG; Lording DW; Allan CA; Zajac JD; Burger HG
Med J Aust; 2016 Aug; 205(4):173-8. PubMed ID: 27510348
[TBL] [Abstract][Full Text] [Related]
7. Endocrine Society of Australia position statement on male hypogonadism (part 2): treatment and therapeutic considerations.
Yeap BB; Grossmann M; McLachlan RI; Handelsman DJ; Wittert GA; Conway AJ; Stuckey BG; Lording DW; Allan CA; Zajac JD; Burger HG
Med J Aust; 2016 Sep; 205(5):228-31. PubMed ID: 27581270
[TBL] [Abstract][Full Text] [Related]
8. [Testosterone replacement treatment in older people with and without co-morbidities].
Zitzmann M
Internist (Berl); 2020 Jun; 61(6):549-557. PubMed ID: 32377774
[TBL] [Abstract][Full Text] [Related]
9. [Pathogenesis, evaluation and treatment of hypogonadism in men].
Rabijewski M; Zgliczyński W
Endokrynol Pol; 2009; 60(3):222-33. PubMed ID: 19569024
[TBL] [Abstract][Full Text] [Related]
10. Evolving issues in male hypogonadism: evaluation, management, and related comorbidities.
Miner MM; Sadovsky R
Cleve Clin J Med; 2007 May; 74 Suppl 3():S38-46. PubMed ID: 17549824
[TBL] [Abstract][Full Text] [Related]
11. Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism.
Giagulli VA; Carbone MD; Ramunni MI; Licchelli B; De Pergola G; Sabbà C; Guastamacchia E; Triggiani V
Andrology; 2015 Nov; 3(6):1094-103. PubMed ID: 26447645
[TBL] [Abstract][Full Text] [Related]
12. Hormonal therapy of male hypogonadism.
Matsumoto AM
Endocrinol Metab Clin North Am; 1994 Dec; 23(4):857-75. PubMed ID: 7705324
[TBL] [Abstract][Full Text] [Related]
13. Androgen therapy in the aging male.
Lunenfeld B
World J Urol; 2003 Nov; 21(5):292-305. PubMed ID: 14576959
[TBL] [Abstract][Full Text] [Related]
14. Testosterone replacement therapy: who to evaluate, what to use, how to follow, and who is at risk?
Afiadata A; Ellsworth P
Hosp Pract (1995); 2014 Dec; 42(5):69-82. PubMed ID: 25485919
[TBL] [Abstract][Full Text] [Related]
15. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
Miner M; Canty DJ; Shabsigh R
Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
[TBL] [Abstract][Full Text] [Related]
16. Importance of hypogonadism and testosterone replacement therapy in current urologic practice: a review.
Hellstrom WJ; Paduch D; Donatucci CF
Int Urol Nephrol; 2012 Feb; 44(1):61-70. PubMed ID: 21152980
[TBL] [Abstract][Full Text] [Related]
17. A phase IV prospective evaluation of the safety and efficacy of extended release testosterone pellets for the treatment of male hypogonadism.
Kaminetsky JC; Moclair B; Hemani M; Sand M
J Sex Med; 2011 Apr; 8(4):1186-96. PubMed ID: 21269402
[TBL] [Abstract][Full Text] [Related]
18. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.
Lunenfeld B; Mskhalaya G; Zitzmann M; Arver S; Kalinchenko S; Tishova Y; Morgentaler A
Aging Male; 2015 Mar; 18(1):5-15. PubMed ID: 25657080
[TBL] [Abstract][Full Text] [Related]
19. Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? -a multicentre prospective study of hCG/rFSH treatment outcomes during adolescence.
Rohayem J; Hauffa BP; Zacharin M; Kliesch S; Zitzmann M;
Clin Endocrinol (Oxf); 2017 Jan; 86(1):75-87. PubMed ID: 27467188
[TBL] [Abstract][Full Text] [Related]
20. Testosterone supplementation does not worsen lower urinary tract symptoms.
Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
